verastem.com (VSTM): Operating Margin

Official company branding of Verastem Corp (VSTM)

Verastem, Inc. (VSTM) delegates primary testing to external centers while retaining ownership of the molecules. The operating margin profile reflects the dynamics of these processes, where -193.70 describes the current status of the metric. A fabless synthesis method, despite high R&D expenditures, promises future superprofits. However, geopolitical tensions and sanctions could slow down international research and the logistics of biomaterials.

VSTM - Verastem Oncology Operating Profit Rate over the range 07/04/2022 - 11/19/2026

Verastem, Inc. - analytical breakdowns and key metrics (VSTM)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
Fundamental company analysis:VSTM, Verastem Inc
Finished products of Verastem Corp

Operating margin reflects the share of profit from core operations before taxes and interest obligations relative to total revenue. For Verastem, Inc. (VSTM), this figure is negative due to high costs associated with late-stage clinical trials. An analysis of operational profitability demonstrates inverted leverage and the dominance of fixed costs. This metric allows for an assessment of resource management efficiency. It is critical for investors to track the trend of reducing operating losses.